390 related articles for article (PubMed ID: 11925293)
1. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia.
Sernyak MJ; Leslie DL; Alarcon RD; Losonczy MF; Rosenheck R
Am J Psychiatry; 2002 Apr; 159(4):561-6. PubMed ID: 11925293
[TBL] [Abstract][Full Text] [Related]
2. Two new atypical antipsychotics: advantages and disadvantages.
Lemon MD
S D J Med; 1998 Aug; 51(8):285-6. PubMed ID: 9724957
[No Abstract] [Full Text] [Related]
3. Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.
Atmaca M; Kuloglu M; Tezcan E; Ustundag B
J Clin Psychiatry; 2003 May; 64(5):598-604. PubMed ID: 12755665
[TBL] [Abstract][Full Text] [Related]
4. From conventional to atypical antipsychotics and back: dynamic processes in the diffusion of new medications.
Leslie DL; Rosenheck RA
Am J Psychiatry; 2002 Sep; 159(9):1534-40. PubMed ID: 12202274
[TBL] [Abstract][Full Text] [Related]
5. Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study.
Bobes J; Garc A-Portilla MP; Rejas J; Hern Ndez G; Garcia-Garcia M; Rico-Villademoros F; Porras A
J Sex Marital Ther; 2003; 29(2):125-47. PubMed ID: 12623765
[TBL] [Abstract][Full Text] [Related]
6. The value of atypical antipsychotics in the treatment of schizophrenia.
Jessen LM
Manag Care; 2002 Jul; 11(7 Suppl):8-12; discussion 12-3. PubMed ID: 12181875
[No Abstract] [Full Text] [Related]
7. Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database.
Gianfrancesco FD; Grogg AL; Mahmoud RA; Wang RH; Nasrallah HA
J Clin Psychiatry; 2002 Oct; 63(10):920-30. PubMed ID: 12416602
[TBL] [Abstract][Full Text] [Related]
8. The new antipsychotic compounds: is a clinical choice algorithm possible?
Wirshing WC
West J Med; 1998 Jul; 169(1):43-4. PubMed ID: 9682633
[No Abstract] [Full Text] [Related]
9. Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study.
Bobes J; Rejas J; Garcia-Garcia M; Rico-Villademoros F; García-Portilla MP; Fernández I; Hernández G;
Schizophr Res; 2003 Jul; 62(1-2):77-88. PubMed ID: 12765747
[TBL] [Abstract][Full Text] [Related]
10. Atypical neuroleptics in child and adolescent psychiatry.
Remschmidt H; Hennighausen K; Clement HW; Heiser P; Schulz E
Eur Child Adolesc Psychiatry; 2000; 9 Suppl 1():I9-19. PubMed ID: 11140784
[TBL] [Abstract][Full Text] [Related]
11. The effects of novel antipsychotics on glucose and lipid levels.
Wirshing DA; Boyd JA; Meng LR; Ballon JS; Marder SR; Wirshing WC
J Clin Psychiatry; 2002 Oct; 63(10):856-65. PubMed ID: 12416594
[TBL] [Abstract][Full Text] [Related]
12. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
[TBL] [Abstract][Full Text] [Related]
13. Massive increase in serum creatine kinase during olanzapine and quetiapine treatment, not during treatment with clozapine.
Boot E; de Haan L
Psychopharmacology (Berl); 2000 Jun; 150(3):347-8. PubMed ID: 10923763
[No Abstract] [Full Text] [Related]
14. Agranulocytosis and neutropenia with typical and atypical neuroleptics.
Hong X; Wang X
Am J Psychiatry; 2001 Oct; 158(10):1736-7. PubMed ID: 11579015
[No Abstract] [Full Text] [Related]
15. The effects of risperidone and olanzapine on the indications for clozapine.
Ganguli R; Brar JS
Psychopharmacol Bull; 1998; 34(1):83-7. PubMed ID: 9564203
[TBL] [Abstract][Full Text] [Related]
16. Weight gain and antipsychotic medication: differences between antipsychotic-free and treatment periods.
Simpson MM; Goetz RR; Devlin MJ; Goetz SA; Walsh BT
J Clin Psychiatry; 2001 Sep; 62(9):694-700. PubMed ID: 11681765
[TBL] [Abstract][Full Text] [Related]
17. Conventional vs. newer antipsychotics in elderly patients.
Jeste DV; Rockwell E; Harris MJ; Lohr JB; Lacro J
Am J Geriatr Psychiatry; 1999; 7(1):70-6. PubMed ID: 9919323
[TBL] [Abstract][Full Text] [Related]
18. Measuring outcome in schizophrenia: differences among the atypical antipsychotics. Collaborative Working Group on Clinical Trial Evaluations.
J Clin Psychiatry; 1998; 59 Suppl 12():3-9. PubMed ID: 9766613
[TBL] [Abstract][Full Text] [Related]
19. Tardive dyskinesia in older patients.
Jeste DV
J Clin Psychiatry; 2000; 61 Suppl 4():27-32. PubMed ID: 10739328
[TBL] [Abstract][Full Text] [Related]
20. Use of atypical neuroleptics in child and adolescent psychiatry.
Toren P; Laor N; Weizman A
J Clin Psychiatry; 1998 Dec; 59(12):644-56. PubMed ID: 9921698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
